RFC
TBPH icon

Russell Frank Company’s Theravance Biopharma TBPH Stock Holding History

Russell Frank Company’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$115K Buy
+6,100
New +$99.8K ﹤0.01% 2768
2014
Q4 		– Sell
-290
Closed -$7K – 3029
2014
Q3 		$7K Buy
+290
New +$8.41K ﹤0.01% 2827

Other funds holding TBPH

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Russell Frank Company's TBPH Position: Q1 2016 in Review

Russell Frank Company opened a new position in Theravance Biopharma (TBPH) in Q1 2016: 6,100 shares worth $115K. The stake represents ﹤0.01% of the portfolio and ranks #2768 among its holdings. This is a return to the name: Russell Frank Company previously reported a position in TBPH as recently as Q3 2014.

Russell Frank Company first reported a position in TBPH in Q3 2014 and has held it in 2 quarters since. 81 funds tracked by Wall St. Rank hold TBPH as of Q1 2016.

  • Russell Frank Company held 6,100 shares of Theravance Biopharma worth $115K as of Q1 2016.
  • Theravance Biopharma was a new Russell Frank Company position in Q1 2016.
  • Theravance Biopharma made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2768 holding.
  • Russell Frank Company first reported a position in Theravance Biopharma in Q3 2014 and has held it in 2 quarters since.
  • 81 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.